Several of the leading international synthetic biology companies have joined together to form the
International Consortium for Polynucleotide Synthesis (ICPS). The primary mission of the ICPS is to
promote safety and security in the promising field of synthetic biology. As part of this mission, the
ICPS member organizations will work together to develop technologies that improve safety and security
in synthetic biology. In addition, the ICPS plans to work with governmental organizations to help facilitate
the creation of a governance framework
and associated safety protocols to foster an appropriate regulatory environment for the synthetic biology industry.
